Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity
Launched by HOSPITAL DE BASE · Feb 15, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
•BACKGROUND It is estimated that 1 in 4 adults suffers from hypertension, including 40% of those over the age of 25. Blood pressure tends to be higher in older adults, and in developed countries, an estimated 9 in 10 adults who live to 80 years of age will develop hypertension. Over the decades, data have shown a positive and continued association between BP values and the occurrence of heart attacks and strokes.
Artery stiffening (AS) and increased pulsatile diameter were identified as standard features of hypertension in individuals aged between 40 and 50 years, and have emerged as two o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- - Individuals older than 18 with an elevated office blood pressure :
- • suspected hypertension diagnosis or
- • uncontrolled hypertension under treatment
- Exclusion Criteria:
- 24-hour ABPM recordings presenting:
- • less than 70% of the expected measurements or
- • fewer than 20 valid awake or seven valid sleeping measurements or
- • fewer than two valid daytime and one valid night-time measurement per hour
About Hospital De Base
Hospital de Base is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through rigorous clinical trials. With a strong focus on innovation and safety, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct a wide range of studies across various therapeutic areas. Committed to ethical standards and regulatory compliance, Hospital de Base fosters collaborations with academic institutions and industry partners to facilitate the development of cutting-edge therapies, ultimately enhancing the quality of care for its diverse patient population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uberaba, Minas Gerais, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported